Press release
Viral Vector Production Research Use Market: Industry Trends, Analysis, Types, Growth, Opportunity and Forecast 2022-2033
This growth is fueled by the rising prevalence of infectious diseases, cancer, and genetic disorders, along with an increasing number of clinical trials and strong funding for gene therapy development. Advances in drug delivery methods further support market expansion. However, high production costs and technological challenges pose hurdles for manufacturers.
Despite these obstacles, the market is expected to expand significantly due to improved clinical outcomes and regulatory support. The growing burden of chronic diseases has increased the demand for viral vectors, which are essential in gene therapy research and development.
Download Free Exclusive Sample PDF@https://www.emergenresearch.com/request-sample/3472
Market Trends and Developments
Companies in the industry are adopting innovative strategies to boost productivity, expand manufacturing capacities, and reduce costs. For instance, Avid Bioservices, Inc. inaugurated its state-of-the-art viral vector development and manufacturing facility in June 2022. The facility's Current Good Manufacturing Plant (CGMP) production suites are expected to be fully operational by mid-2023, reinforcing the market's growth momentum.
Key Market Drivers
Effectiveness of Viral Vectors: Viral vectors play a crucial role in delivering therapeutic genes for gene therapy. They are widely used due to their ability to efficiently target and enter cells. These vectors can be modified for specific applications, making them essential tools in modern medical treatments.
High Demand for Gene and Cell Therapy: With over 1,000 gene and cell therapies under development worldwide, the need for viral vector production has surged. The increasing adoption of gene therapy for various diseases is further driving market growth.
Market Challenges
High Production Costs: Manufacturing viral vectors remains costly. Traditional production methods, such as adherent manufacturing, require significant investment. Producing viral vectors for gene therapy can cost between USD 500,000 to USD 1 million, making affordability a challenge for many companies.
Interested in knowing more relevant information? Click here:https://www.emergenresearch.com/industry-report/viral-vector-production-research-use-market
Market Segmentation
By vector type, the market is segmented into adeno-associated virus (AAV), lentivirus, retrovirus, and others.
Adeno-Associated Virus (AAV) Leading the Market: AAV vectors dominate the market due to their extensive use in gene therapy, genome editing, and vaccine development. Growing clinical research and strong industry investment have boosted this segment.
Lentivirus Expected to See Rapid Growth: Lentivirus vectors are gaining popularity due to their use in cancer immunotherapy, regenerative medicine, and genetic disorder treatment. Their flexibility and effectiveness in gene therapy are driving increased adoption.
Viral Vector Production Research Use Top Companies and Competitive Landscape
FUJIFILM Diosynth Biotechnologies U.S.A., Inc, Thermo Fisher Scientific, Charles River Laboratories and Merck KgaA are the key players in the industry. The market competition in this field is expected to intensify due to the ongoing expansion of businesses involved in the development of vaccines and gene and cell therapies. Additionally, a significant increase in service demand is being observed by contract research firms, which is boosting their revenue creation.
In October 2022, In order to give developers a more effective route to plasmid DNA and viral vector manufacturing, the ABL organization and RD-Biotech formed a strategic cooperation in GMP manufacturing for cell and gene therapy.
Some of the key companies in the global Viral Vector Production Research Use Market include:
Merck KGaA
Lonza
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
Charles River Laboratories.
Thermo Fisher Scientific
Waisman Biomanufacturing
Genezen
Yposkesi,Inc.
Advanced BioScience Laboratories, Inc. (ABL, Inc.)
Orgenesis Inc.
Viral Vector Production Research Use Latest Industry Updates
ProBio announced in June 2024 that it will be expanding its capacity to manufacture viral vectors and plasmid DNA by constructing a new facility in the United States.
MassBiologics was awarded USD 5 million in April 2024 to establish a facility for manufacturing viral vectors.
Make Payment [Buy your Exclusive copy] @https://www.emergenresearch.com/select-license/3472
The main report offers detailed historical data and forecasts revenue growth at a global, regional, and country level, and provides analysis of the market trends in each of the segments from 2020 to 2033:
Viral Vector Production Research Use Market Segmentation Analysis
Vector Type Outlook (Revenue, USD Million; 2020-2033)
Adeno-associated Virus (AAV)
Lentivirus
Adenovirus
Retrovirus
Others
Application Outlook (Revenue, USD Million; 2020-2033)
Cell & Gene Therapy Development
Vaccine Development
Biopharmaceutical & Pharmaceutical Discovery
Biomedical Research
Workflow Outlook (Revenue, USD Million; 2020-2033)
Upstream Processing
Vector Amplification & Expansion
Vector Recovery & Harvesting
Downstream Processing
Purification
Fill-finish
End Use Outlook (Revenue, USD Million; 2020-2033)
Pharmaceutical and Biopharmaceutical Companies
Research Institutes
Regional Outlook (Revenue, USD Million; 2020-2033)
North America
United States
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Benelux
Rest of Europe
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Rest of Latin America
Middle East and Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
Request Customization in The Report @ https://www.emergenresearch.com/request-for-customization/3472
Look Over transcripts provided by Emergen Research
Viral Vector Production Research Use Market Size @https://www.emergenresearch.com/industry-report/viral-vector-production-research-use-market/market-size
Viral Vector Production Research Use Market Share @https://www.emergenresearch.com/industry-report/viral-vector-production-research-use-market/market-share
Viral Vector Production Research Use Market Trends @https://www.emergenresearch.com/industry-report/viral-vector-production-research-use-market/market-trends
Viral Vector Production Research Use Regional Market Demand @https://www.emergenresearch.com/industry-report/viral-vector-production-research-use-market/regional-market-demand
Viral Vector Production Research Use Market Analysis @https://www.emergenresearch.com/industry-report/viral-vector-production-research-use-market/market-analysis
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Viral Vector Production Research Use Market: Industry Trends, Analysis, Types, Growth, Opportunity and Forecast 2022-2033 here
News-ID: 3841862 • Views: …
More Releases from Emergen Research
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for Vector
Growing Prevalence Of Vector-Borne Diseases Fuels Vector Control Market: Pivotal …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Vector Control Market Size Growth Forecast: What to Expect by 2025?
The market size of vector control has been experiencing robust growth in the past years, and it's predicted to increase from $20.53 billion in 2024 to $22.01 billion in 2025, with a compound annual growth rate (CAGR) of 7.2%. Factors such as urbanization…
Global Viral Vector Manufacturing Market Size by Application, Type, and Geograph …
USA, New Jersey- According to Market Research Intellect, the global Viral Vector Manufacturing market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The viral vector manufacturing market is witnessing accelerated growth due to the rising demand for gene therapies and vaccines. These vectors are essential tools…
Prominent Viral Vector Manufacturing Market Trend for 2025: Product Innovation I …
How Are the key drivers contributing to the expansion of the viral vector manufacturing market?
The escalation in the occurrence of both cancer and contagious diseases is anticipated to spur the expansion of the viral vector manufacturing market in the future. An infectious disease is a condition caused by a virus or its harmful byproduct which spreads to a susceptible organism through contact with an infected individual, creature, or object. Cancer…
Emerging Lentiviral Vector Market Trend 2025-2034: Technological Advancements In …
How Is the Lentiviral Vector Market Projected to Grow, and What Is Its Market Size?
The lentiviral vector market will grow from $14.37 billion in 2024 to $16.62 billion in 2025, at a CAGR of 15.7%. This market is expanding due to the growing prevalence of genetic disorders, increasing demand for gene delivery systems, biotech and pharmaceutical investments, and regulatory approvals for related therapies.
The lentiviral vector market is expected to grow…
Viral Vector Manufacturing Market Report 2024 - Viral Vector Manufacturing Marke …
"The Business Research Company recently released a comprehensive report on the Global Viral Vector Manufacturing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Adeno-Associated Virus Vector Manufacturing Market - Building Better Therapies: …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Adeno-Associated Virus Vector Manufacturing Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Adeno-Associated Virus Vector Manufacturing provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and…
